The Effects of Reducing Stomach Acid on Post-tonsillectomy Pain
The Effects of Gastro-esophageal Acid Suppression on Post-tonsillectomy Pain
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
This study has been limited to children and adolescents ages 5-18 who are undergoing tonsillectomy for an indication of obstructive sleep disturbance (snoring, choking/gasping or pauses in breathing during sleep.)
Study participants will be randomized to two groups: study medication (Lansoprazole) or an inactive substance(placebo).
Participants will be asked to do all of the following:
- Take the study medication twice a day for 14 days.
Keep a log book which will include:
- Record the medications and amount of each medication taken each day for 14 days. This includes pain medication and the study drug.
- Record your child's activity level daily for 14 days.
- Collect your child's urine one time daily and test it using special medicated strips to monitor their daily liquid intake for 14 days.
- Meet with a Research Assistant or Study Physician 14-21 days after the study to collect the log book and perform a post-operative examination.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Children's Hospital Boston
-
Boston, Massachusetts, United States, 02115
- Childrens Hospital Boston
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All healthy children ages 5-18 years scheduled for tonsillectomy and /or adenotonsillectomy for sleep disturbance secondary to airway obstruction at Children's Hospital Boston
Exclusion Criteria:
- Patients on any medications other than the study drug (Lansoprazole or placebo), Amoxicillin®, and acetaminophen with or without codeine
- An underlying medical condition which would necessitate an alteration in the anesthetic regimen
- Patients allergic to any of the medications in the protocol
- History of chronic tonsillitis
- History of chronic pain conditions
- History of active gastro-esophageal reflux disease
- Surgery in addition to tonsillectomy/adenotonsillectomy (except for myringotomy)
- Cognitive/developmental disorders
- Inability to use a self-report pain scale
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: 2
Placebo
|
Placebo will also be administered based on weight.
|
|
Experimental: 1
Post-operative administration of Lansoprazole
|
If weight is less than 30 kg, 15 mg of Lansoprazole twice daily will be administered.
If weight is greater than or equal to 30 kg, 30 mg of Lansoprazole twice daily will be administered.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The Primary Outcome is the Number of Days to Become Free of Narcotic Pain Medication.
Time Frame: 2 weeks
|
2 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The Secondary Outcomes Are the Number of Days to be Free of Pain, the Number of Days to Return to Normal Activity Levels and the Number of Days to Return to Normal Fluid Intake.
Time Frame: 2 weeks
|
2 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Manali Amin, MD, Children's Hosptial Boston
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 06-11-0513
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.